The Role of the Pharmacist in Optimizing Treatment Options and Monitoring Abuse in ADHD Medications
Supported by an educational grant from Mallinckrodt Pharmaceuticals.
Megan J. Ehret, PharmD, MS, BCPP
University of Connecticut
After completing this continuing education program, the participant will be able to:
- List the current medications, appropriate dosing, and alternative formulations available for ADHD treatment.
- State the substance abuse landscape as it relates to ADHD.
- Review data on the pharmacist’s role as gatekeeper for ADHD medications.
Type of activity:
April 6, 2015
April 6, 2017
Estimated time to complete activity:
Pharmacy Times Office of Continuing Professional Education is accredited by the accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-15-028-H01-P. The activity is available for CE credit through April 6, 2017.